Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–Horizon Pharma plc (Nasdaq: HZNP) today announced that it will present additional results from its Phase 3 confirmatory clinical…
Science2Startup Symposium Will Take Place in Cambridge on April 23, 2019, at the Broad Institute of MIT and Harvard Science2Startup…
Genbase Biotechnology unveils innovative new drug research for treatment of gastric/pancreatic cancer and solid tumors ATLANTA–(BUSINESS WIRE)–Aiming to help accelerate…
PASADENA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24arwr&src=ctag" target="_blank"gt;$arwrlt;/agt; lt;a href="https://twitter.com/hashtag/ILC2019?src=hash" target="_blank"gt;#ILC2019lt;/agt;–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today presented preclinical data at The International Liver…
FOSTER CITY, Calif. & BAGSVÆRD, Denmark–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ: GILD) and Novo Nordisk A/S (NASDAQ Copenhagen: NOVO B) today…
FOSTER CITY, Calif. & BAGSVÆRD, Denmark–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ: GILD) and Novo Nordisk A/S (NASDAQ Copenhagen: NOVO B) today…
KEYTRUDA Now Approved for First-Line Treatment of Patients with Stage III NSCLC Who Are Not Candidates for Surgical Resection or…
Appointments effective as of April 29, 2019 Dr. Richard M. Glickman to retire from executive and board roles and remain…
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) todayannounced the launch of a generic version of AndroGel ®i(testosterone gel) 1.62% CIII in the U.S.
Ophtotech entered into an exclusive global licenseagreement for rights to developand commercialize novel adeno-associated virus (AAV) gene therapyproduct candidates for the treatment of Best vitelliform maculardystrophy.